insights_auto
Why is SABS down 3,44%?
Dive Deeperchevron_right
SABS:NASDAQ
SAB Biotherapeutics Inc
2,81 US$
arrow_downward
-3,44%(-0,10) 1D
2,81 US$
0,00% (0,00)
bedtimeAfter hours
Closed: 20 ნოე, 16:00:01 GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for SABS...
Open
2,79 US$
High
2,88 US$
Low
2,64 US$
Mkt. cap
253,15 მლნ.
Avg. vol.
709,90 ათ.
Volume
874,57 ათ.
52-wk high
5,15 US$
52-wk low
2,44 US$
EPS
-0,93 US$
Beta
0,67
Shares outstanding
90,09 მლნ.
No. of employees
86
Open
2,79 US$
High
2,88 US$
Low
2,64 US$
Mkt. cap
253,15 მლნ.
Avg. vol.
709,90 ათ.
Volume
874,57 ათ.
52-wk high
5,15 US$
52-wk low
2,44 US$
EPS
-0,93 US$
Beta
0,67
Shares outstanding
90,09 მლნ.
No. of employees
86
News stories
From web sources and news partners
The Motley Fool
·
11 წუთის წინ
Report: Goldman Sachs Predicts the S&P 500 Will Gain 26% in 12 Months
marketscreener.com
·
22 წუთის წინ
Nasdaq has its worst week since 2020; Dow, S&P 500 in correction
Benzinga
·
55 წუთის წინ
Veteran, 41, Put $500K Into The S&P 500. Dave Ramsey Says It Could Hit $8 By Age 69 ‘If You Just Don’t Touch It’
FXStreet
·
3 საათის წინ
Dow Jones Industrial Average drops for a fifth day as AI rout widens
About SAB Biotherapeutics Inc
CEO-
Employees86
Founded2014
Headquartersმაიამი-ბიჩი, ფლორიდა, ამერიკის შეერთებული შტატები
SectorHealth Care
Industry-
Websitesab.bio